Rett syndrome: Review of biological abnormalities

Canadian Journal of Neurological Sciences

Volumn 28, Issue 1, 2001, Pages 16-29

  Dunn, H G ^a   MacLeod, P M ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BRAIN PROTEIN; CHOLINE ACETYLTRANSFERASE; DNA; DOPAMINE; ENDORPHIN; GLUTAMIC ACID; METHYLCYTOSINE BINDING PROTEIN 2; NERVE GROWTH FACTOR; NORADRENALIN; SEROTONIN; SUBSTANCE P; UNCLASSIFIED DRUG;

CLINICAL FEATURE; DNA METHYLATION; ELECTROPHYSIOLOGY; FEMININITY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; RETT SYNDROME; REVIEW; SEX DIFFERENCE; X CHROMOSOME LINKED DISORDER;

EID: 0035108653     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100052513     Document Type: Review

References (160)

1. Über ein eigenartiges himatrophisches syndrom bei hyperammonämie im kindesalter
2. A new syndrome (?) of progressive psychomotor deterioration with peculiar stereotype movement and autistic tendency: A report of three cases
3. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: Report of 35 cases
4. Rett syndrome: A suggested staging system for describing impairment profile with increasing age towards adolescence
5. Diagnostic criteria for Rett syndrome
6. Rett variants: A suggested model for inclusion criteria
7. The Rett girls with preserved speech
8. Osteopenia in Rett syndrome
9. A population-based approach to the investigation of osteopenia in Rett syndrome
10. Metacarpophalangeal pattern profile and bone age in Rett syndrome: Further radiological clues to the diagnosis
11. Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome
12. Air swallowing in Rett syndrome
13. Rett's syndrome: Prevalence and impact on progressive severe mental retardation in girls
14. Rett's syndrome in the West of Scotland
15. Rett syndrome in Sweden
16. Rett syndrome: The Swedish Genealogic Research Project. New data and present position
17. Rett syndrome, classical and atypical: Genealogical support for common origin
18. Rett syndrome in northern Tuscany: Family tree studies
19. Pedigree analysis of Hungarian Rett syndrome girls
20. The prevalence and incidence of Rett syndrome in Australia
21. Rett syndrome: Geographic variation in prevalence in Norway
22. Mother and daughter with Rett syndrome
23. Exploring the male phenotype
24. Cytogenetic and molecular-cytogenetic studies of Rett syndrome (RTT). A retrospective analysis of Russian cohort of RTT patients
25. Neonatal encephalopathy in two boys in families with recurrent Rett syndrome
26. Rett syndrome and beyond: Recurrent spontaneous and familial MECP2 mutations at CPG hotspots
27. Patterns of X chromosome inactivation in the Rett syndrome
28. Examination of X chromosome markers in Rett syndrome: Exclusion mapping with a novel variation on multilocus linkage analysis
29. A severely affected male born into a Rett syndrome kindred supports X-linked inheritance and allows extension of the exclusion map
30. Rett syndrome: Confirmation of X-linked dominant inheritance, and localization of the gene to Xq28
31. Chromosome mapping of Rett syndrome: A likely candidate region on the telomere of Xq
32. Linkage analysis in Rett syndrome families suggests that there may be a critical region at Xq28
33. Molecular approaches to the Rett syndrome gene
34. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2
35. Breaking the silence in Rett syndrome
36. Methylation moves into medicine
37. Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9 and 16, and facial anomalies: The ICF syndrome
38. Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes
39. Rett syndrome: Analysis of MeCP2 and clinical characterization of 31 patients
40. Methyl-CpG binding protein 2 mutations in Rett syndrome
41. Spectrum of MECP2 mutations in Rett syndrome
42. Long-read sequence analysis of the MECP2 gene in Rett syndrome patients: Correlation of disease severity with mutation type and location
43. Biological function of the methyl-CPG binding protein MECP2
44. MECP2 and Rett Syndrome (RS) - Time for a mutation database?
45. Is the girl with Rett syndrome normal at birth?
46. Neuropathology of Rett syndrome
47. Microscopic observations of the brain in Rett syndrome
48. Rett syndrome: Cerebellar pathology
49. The neuropathology of Rett syndrome: Overview 1994
50. Peripheral nerve findings in Rett syndrome
51. Rett syndrome: Spinal cord neuropathy
52. Peripheral nerve involvement in the Rett syndrome
53. Preliminary evidence for neurodegenerative changes in the substantia nigra of Rett syndrome
54. Morphological study of neocortical areas in Rett syndrome
55. Clinical features of the early stage of the Rett syndrome
56. Age related occurrence of signs and symptoms in the Rett syndrome
57. Rett syndrome studies of natural history and search for a genetic marker
58. Rett's syndrome: Correlation of electroencephalographic characteristics with clinical staging
59. Rett syndrome: EEG presentation
60. Rett syndrome: Clinical profile and EEG abnormalities
61. Further EEG observations in children with the Rett syndrome
62. EEG and respiration in Rett syndrome
63. Unusual EEG theta rhythms over central region in Rett syndrome: Considerations of the underlying dysfunction
64. Rett syndrome: Characterization of seizures versus nonseizures
65. Cortical reflex myoclonus in Rett syndrome
66. Abnormal cortical excitability in Rett syndrome
67. Transcranial magnetic stimulation in patients with Rett syndrome: Preliminary results
68. Characteristic response to transcranial magnetic stimulation in Rett syndrome
69. Brain stem and spinal cord impairment in Rett syndrome: Somatosensory and auditory evoked responses investigations
70. Neurophysiological findings in the Rett syndrome, 1:EMG, conduction velocity, EEG and somatosensory-evoked potential studies
71. Rett syndrome - Clinical studies and pathophysiological considerations
72. Rett syndrome - An early catecholamine and indolamine deficient disorder?
73. Anatomy of Rett syndrome
74. Pathophysiology of the Rett syndrome from the standpoint of polysomnography
75. Polysomnography in the Rett syndrome
76. Evidence for a neurotrophic role of noradrenaline neurons in the postnatal development of rat cerebral cortex
77. Cerebrospinal fluid values for monoamine metabolites, gamma aminobutyric acid, and other amino compounds in Rett syndrome
78. CSF and urine biogenic amine metabolites in Rett syndrome
79. Rett syndrome: Biogenic amines and metabolites in postmortem brain
80. Altered neurochemical markers in Rett syndrome
81. Altered neurochemical markers in Rett's syndrome
82. Neurobiology of Rett syndrome
83. The effects of neonatal basal forebrain lesions on cognition: Towards understanding the developmental role of the cholinergic basal forebrain
84. Alterations in dopaminergic function in Rett syndrome
85. Rett syndrome: Evidence for normal dopaminergic function
86. Abnormalities in neuronal maturation in Rett syndrome neocortex: Preliminary molecular correlates
87. Rett syndrome: A disorder affecting early brain growth
88. Regulation of TrkA and ChAT expression in developing rat basal forebrain: Evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons
89. GDNF: A glial cell line derived neurotrophic factor for midbrain dopaminergic neurons
90. Low levels of nerve growth factor in cerebrospinal fluid of children with Rett syndrome
91. Neurotrophic factors in cerebrospinal fluid and serum of patients with Rett syndrome
92. Levels of cerebrospinal fluid nerve-growth factor differ in infantile autism and Rett syndrome
93. Altered cholinergic function in the basal forebrain of girls with Rett syndrome
94. Cholinergic regulation of cortical development and plasticity. New twists to an old story
95. Involvement of the autonomic nervous system in the pathophysiology of Rett syndrome
96. Functional evidence of brain stem immaturity in Rett syndrome
97. Electrocardiographic findings in Rett syndrome: Explanation for sudden death?
98. Case Reports: Anaesthesia for Rett Syndrome
99. Prolonged QT interval in Rett syndrome
100. Reduced heart rate variability in patients affected with Rett syndrome. A possible explanation for sudden death
101. Workshop on autonomic function in Rett syndrome. Swedish Rett Center, Frösön, Sweden, May 1998
102. Rett syndrome, one-sided sympathectomy. Unilateral foot normalization
103. Topographic projections of Substance P and GABA pathways in the striato-and pallido-nigral system: A biochemical and immunohistochemical study
104. Reinforcing effects of neurokinin Substance P in the ventral pallidum: Mediation by the tachykinin NKI receptor
105. Distinct mechanism for antidepressant activity by blockade of central Substance P receptors
106. Substance P as a transmitter candidate
107. Elevation of Substance P-like peptides in the CSF of psychiatric patients
108. Elevated cerebrospinal fluid levels of Substance P in patients with the fibromyalgia syndrome
109. Decreased cerebrospinal fluid levels of Substance P in patients with Rett syndrome
110. Substance P immunoreactivity in Rett syndrome
111. Abnormal carbohydrate metabolism in cerebrospinal fluid in Rett syndrome
112. Oxidative metabolism in Rett syndrome: 2. Biochemical and molecular studies
113. Cerebrospinal fluid studies in the Rett syndrome: Biogenic amines and beta endorphins
114. Cerebrospinal fluid β-endorphin and cortisol study in Rett syndrome
115. Cerebrospinal fluid β-endorphin in Rett syndrome
116. Elevated CSF β-endorphin immunoreactivity in Rett's syndrome: Report of 158 cases and comparison with leukemic children
117. Rett syndrome: Controlled study of an oral opiate antagonist, naltrexone
118. Membrane cerebral lipids in Rett syndrome
119. Cerebrospinal fluid gangliosides in patients with Rett syndrome and infantile neuronal ceroid lipofuscinosis
120. Elevated CSF glutamate in Rett syndrome
121. High levels of cerebrospinal fluid glutamate in Rett syndrome
122. Lamotrigine in Rett syndrome
123. Lamotrigine in Rett syndrome: Treatment experience from a pilot study
124. LTG therapy in 5 patients with Rett syndrome and epilepsy with the onset in the first 24 months of age
125. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development
126. Development of amino acid receptors in frontal cortex from girls with Rett syndrome
127. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children
128. Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome
129. Decreased cerebrospinal fluid levels of β-phenylethylamine in patients with Rett syndrome
130. Quantitative magnetic resonance imaging in Rett syndrome
131. Cerebellar and cerebral abnormalities in Rett syndrome: A quantitative MR analysis
132. Neuroanatomy of Rett syndrome: A volumetric imaging study
133. Neuroanatomy in Rett syndrome: Cerebral cortex and posterior fossa
134. Cerebral magnetic resonance spectroscopy in Rett syndrome. Failure to detect mitochondrial disorder
135. Cerebral proton magnetic resonance spectroscopy in Rett syndrome
136. Proton magnetic resonance spectroscopy of the brain in 3 cases of Rett syndrome: Comparison with autism and normal controls
137. 1H spectroscopic imaging at 4.1 Tesla
138. 1H MR spectroscopic imaging in early Rett syndrome
139. Immature pattern of brain activity in Rett syndrome
140. Brain perfusion SPECT and EEG findings in Rett syndrome
141. Regional cerebral blood flow abnormalities in Rett syndrome
142. 99Tc(m)-ECD
143. Cerebral blood flow and oxygen metabolism in Rett syndrome
144. 2 dopamine receptor binding and CSF biogenic amine metabolites in Rett syndrome
145. 18F] fluorodopa studies correlate with dopamine cell counts and levels
146. Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices
147. 18F] fluoro-Dopa uptake in human striata
148. An interactive technique for three-dimensional image registration: Validation for PET, SPECT, MRI and CT brain studies
149. Dopamine transporter changes in neuropsychiatric disorders
150. 2 receptor SPECT imaging in Rett syndrome: Increase of specific binding in striatum
151. Neuroimaging studies in Rett syndrome
152. Age-dependent decline of nigrostriatal dopaminergic function: A positron emission tomographic study of grandparents and their grandchildren
153. Neurophysiology of Rett syndrome
154. Screening and diagnosis of autism: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society
155. SPECT of the brain in childhood autism: Evidence for a lack of normal hemispheric asymmetry
156. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children
157. Rett syndrome: Significant clinical overlap with Angelman syndrome but not with methylation status
158. Management of Rett syndrome: A ten-year experience
159. Rett syndrome: Habilitation and management reviewed